← All indications
Sleep Wake Disorders
Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.
Subtype terms (3)
More specific conditions that are subtypes of Sleep Wake Disorders in the MeSH hierarchy.
- Dyssomnias
7 drugs (6 approved, 1 experimental)
- Parasomnias
- Sleep Deprivation
34 drugs (24 approved, 10 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (35)
- melatonin
- propofol
- agomelatine
- alprazolam
- mometasone
- suvorexant
- estazolam
- fremanezumab
- escitalopram
- zopiclone
- tenofovir
- guanfacine
- esketamine
- ketorolac
- lorazepam
- nicotine
- ramelteon
- emtricitabine
- estradiol
- trazodone
- diazepam
- yangzhengxiaoji
- zolpidem
- dexmedetomidine
- fentanyl
- bupropion
- flunitrazepam
- multivitamins
- morphine
- melissa
- +5 more
Phase 3 trials (13)
Phase 2 trials (13)
Phase 1 trials (6)
Other trials (30)
- efavirenz
- fluticasone
- iron
- aminolevulinic acid
- buspirone
- paroxetine
- bryophyllum
- citalopram
- salmeterol
- entacapone
- etravirine
- levodopa
- carbidopa
- sitagliptin
- pantoprazole
- clonidine
- cellulose
- raltegravir
- sodium chloride
- somatorelin
- venlafaxine
- glutathione
- saffron
- branched chain amino acids
- fisetin
- wendan
- urolithin a
- fish hydrolysate
- oryza sativa
- suanzaoren
Organizations
Organization Involved with Phase 4 Indications (67)
- Takeda
- Shire
- Forest Laboratories
- Gilead Sciences
- AstraZeneca
- Merck
- Pfizer
- Sanofi
- Wyeth
- Kuhnil Pharmaceutical Co., Ltd.
- Shaanxi Buchang Pharmaceutical Co., Ltd
- SRI International
- Sunovion
- Teva
- Boehringer Ingelheim
- TTY Biopharm
- National Institute of Mental Health (NIMH)
- National Institute on Drug Abuse (NIDA)
- Region Syddanmark
- University of Pennsylvania
- University of Arizona
- University of Pittsburgh
- Chang Gung University
- Cleveland Sleep Research Center
- Children's Specialized Hospital
- Clinique Beau Soleil
- Harvard University
- Inje University
- Johns Hopkins University
- Mental Health Services in the Capital Region, Denmark
- +37 more
Organization Involved with Phase 3 Indications (35)
- XenoPort, Inc.
- Astellas
- Bioprojet
- GlaxoSmithKline
- Neurim Pharmaceuticals Ltd.
- Targeted Medical Pharma
- Nobel Pharmaceuticals
- National Cancer Institute (NCI)
- Herlev Hospital
- Cancer and Leukemia Group B (CALGB)
- University of London
- Hoosier Cancer Research Network
- International Breast Cancer Study Group
- Loma Linda University
- Meander Medical Center
- University of Hamburg
- University of Brasilia
- Kurume University
- Southeast Renal Research Institute
- University of Cincinnati
- University of Copenhagen
- Free University of Amsterdam
- Koege and Roskilde Hospital
- Psychiatric Research Unit, Region Zealand
- National Taiwan University
- Pennsylvania State University
- Neurocenter of Southern Switzerland, Lugano
- Universidade Federal do Parana
- Dutch Kidney Foundation
- Pharma Nord
- +5 more
Organization Involved with Phase 2 Indications (40)
- Sanofi-Synthelabo
- INC Research
- Kyowa Hakko Kirin
- Somnus Therapeutics, Inc.
- The EMMES Corporation
- National Institutes of Health (NIH)
- British Columbia Cancer Agency
- National Center for Complementary and Integrative Health (NCCIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Nursing Research (NINR)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Case Western Reserve University
- Federal University of Health Science of Porto Alegre
- Melbourne Health
- Northern California Institute of Research and Education
- Rhode Island Hospital
- University of Michigan
- Wake Forest University
- University of Zurich
- University of Colorado, Denver
- Department of Defense
- Vince & Associates
- Clinilabs
- Kyowa Kirin
- Broward Research Group
- University of Lyon
- University of Texas at Houston
- Sleep Disorders Center of Atlanta
- Neurotrials Inc.
- Emsellem MD PC
- +10 more
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (18)
- Jazz Pharmaceuticals
- Child Psychopharmacology Institute
- United States Army
- Baylor University
- University of Washington
- Northwestern University
- Oregon Health and Science University
- Universidad de Murcia
- Thomas Jefferson University
- University of Lausanne
- University of Bern
- Yale University
- Institute of Liver and Biliary Sciences, India
- University of Colorado, Boulder
- Ospedale Regionale di Lugano
- Masimo Corporation
- University of Geneva
- Huntington's Disease Society of America